| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/18/2009 | CN101386606A 3-amino-7-dialkylamide substituted phenothiazines compounds and preparation method and use thereof |
| 03/18/2009 | CN101385854A Rabbit hemorrhagic disease vaccine and antigens |
| 03/18/2009 | CN101385467A Novel pesticidal toxins |
| 03/17/2009 | US7504248 Production of viruses viral isolates and vaccines |
| 03/17/2009 | US7504206 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/17/2009 | US7504109 Avian pandemic; immunogens; antibodies; immunology |
| 03/17/2009 | US7504098 Method for introducing a biological molecule using a viral envelope and heparin and system therefore |
| 03/17/2009 | CA2616698C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
| 03/17/2009 | CA2522630C Method of purification of recombinant viral vectors containing a therapeutic gene |
| 03/17/2009 | CA2493558C Methods for detecting or assaying virus |
| 03/13/2009 | CA2597878A1 Capsid protein and use therefore |
| 03/12/2009 | WO2009030025A1 Porcine adeno-associated viruses |
| 03/12/2009 | WO2009009670A3 Apparatus and method for harvesting biologics from eggs |
| 03/12/2009 | WO2008140622A3 Modified polymerases and attenuated viruses and methods of use thereof |
| 03/12/2009 | WO2008109686A3 Non- infectious recombinant virus-like particles and their pharmaceutical applications |
| 03/12/2009 | WO2008022196A3 Development of dengue virus vaccine components |
| 03/12/2009 | US20090069264 Toxoplasma gondii nucleic acid molecules |
| 03/12/2009 | US20090068221 Virus-like particles as vaccines for paramyxovirus |
| 03/12/2009 | US20090068215 Herpes simplex virus mutant icp0 protein |
| 03/12/2009 | US20090068106 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 03/12/2009 | CA2698011A1 Porcine adeno-associated viruses |
| 03/11/2009 | EP2034012A1 Vaccine against viral rabbit hemorrhagic disease |
| 03/11/2009 | EP2033967A1 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 03/11/2009 | EP2032592A1 Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages |
| 03/11/2009 | CN101384714A Novel viral vector |
| 03/11/2009 | CN101381742A Late promoter targeting regulation oncolytic adenovirus pCN305 vector and construction method and application thereof |
| 03/11/2009 | CN101381726A Method for expressing growth factor of human blood vessel in bombyx mori by Bac-to-Bac system |
| 03/11/2009 | CN101380470A Pig parvovirus live vaccine |
| 03/11/2009 | CN101380469A Production technique of turbot reddish body iridovirus inactivated vaccine |
| 03/11/2009 | CN101380468A Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof |
| 03/11/2009 | CN100467591C Recombinant fowl influenza virus strain, its preparation method and the vaccine obtained therefrom |
| 03/11/2009 | CN100467062C Method of production of purified hepatitis A virus particles and vaccine preparation |
| 03/10/2009 | US7501502 Viral vectors with nucleotide sequence operably linked to cytomegalo virus promoter for expression; host cells, genetic engineering; 85P1B3 gene or fragment or its encoded protein which can be used to elicit an immune response; diagnosis |
| 03/10/2009 | US7501491 recombinant viral genome containing a deletion in the glycoprotein genes; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
| 03/10/2009 | CA2467959C Production of adeno-associated virus in insect cells |
| 03/10/2009 | CA2197677C A method of selectively destroying neoplastic cells |
| 03/05/2009 | WO2009029695A1 Method for producing viral vaccines |
| 03/05/2009 | WO2009027412A1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
| 03/05/2009 | WO2009006300A3 Production cell lines for adenoviral manufacturing |
| 03/05/2009 | US20090062514 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification |
| 03/05/2009 | US20090061521 Recombinant negative strand RNA virus expression systems and vaccines |
| 03/05/2009 | US20090061480 Nucleotide sequence encoding a modulator of nf-kb |
| 03/05/2009 | US20090060866 Phosphadiazine hcv polymerase inhibitors i and ii |
| 03/05/2009 | CA2696090A1 Method for producing viral vaccines |
| 03/04/2009 | EP2031069A1 Methods for stable transduction of cells with viral vectors |
| 03/04/2009 | EP2031065A1 A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi |
| 03/04/2009 | EP2029756A1 Process for producing poxviruses and poxvirus compositions |
| 03/04/2009 | EP2029747A1 Detection and use of antiviral resistance mutations |
| 03/04/2009 | EP2029176A2 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 03/04/2009 | EP2029169A2 Recombinant viral vaccine |
| 03/04/2009 | EP1706486B1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 03/04/2009 | EP1252322B2 Herpes virus strains for gene therapy |
| 03/04/2009 | EP1115290B1 Retroviral gene delivery system and methods of use |
| 03/04/2009 | CN101379183A Rescue of influenza virus |
| 03/04/2009 | CN101376885A Method for producing recombinant canine interferon alpha from cultivated silkworm |
| 03/04/2009 | CN101376880A Recombinant new castle disease LaSota attenuated vaccine strain expressing rabies virus glucoprotein (GP protein) |
| 03/04/2009 | CN101376879A Recombinant new castle disease LaSota attenuated vaccine strain expressing bovine interferon (alpha, beta and gamma-interferon) |
| 03/04/2009 | CN101376878A Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby |
| 03/04/2009 | CN100465280C A chicken RNA polymerisate I promoter and an application thereof |
| 03/03/2009 | US7498479 Animal model having a chimeric human liver |
| 03/03/2009 | US7498403 Peptides capable of binding to titanium silver silicone |
| 03/03/2009 | US7498161 Anticarcinogenic agents; gene directed enzyme prodrug therapy |
| 03/03/2009 | US7498024 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 02/26/2009 | WO2009026219A1 Novel clostridium perfringens bacteriophage and uses thereof |
| 02/26/2009 | WO2009000891A3 Linear expression constructs for production of influenza virus particles |
| 02/26/2009 | WO2005116260A3 Influenza hemagglutinin and neuraminidase variants |
| 02/26/2009 | US20090053790 Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell |
| 02/26/2009 | US20090053789 Particle binding |
| 02/26/2009 | US20090053294 Anti Mineralocorticoid Therapy of Infection |
| 02/26/2009 | US20090053264 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 02/26/2009 | US20090053261 Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
| 02/26/2009 | US20090053244 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 02/26/2009 | US20090053201 Using variation in DNA polymerase sequence as diagnostic indicator of adefovir or tenofovir resistance in virus; viricides |
| 02/26/2009 | US20090053186 Therapy for primary and metastatic cancers |
| 02/26/2009 | US20090053178 Use of herpes vectors for tumor therapy |
| 02/26/2009 | US20090053144 Reduction in bacterial colonization by administering bacteriophage compositions |
| 02/25/2009 | EP2028270A2 Modified recombinant vaccina viruses and uses thereof |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP0896058B1 Novel semaphorin z and gene encoding the same |
| 02/25/2009 | CN101372686A Infected protein mediated method for producing recombinant baculovirus particle |
| 02/25/2009 | CN101372685A Zero background constructing method for recombinant baculovirus |
| 02/25/2009 | CN101372684A Method for easily and efficiently constructing recombinant baculovirus |
| 02/25/2009 | CN101372683A Artificial pseudovirus of human hepatitis C, and preparation and application thereof |
| 02/25/2009 | CN100463964C Hybridization immune deficiency virus strain and application |
| 02/24/2009 | US7494813 VAC-BAC shuttle vector system |
| 02/24/2009 | US7494808 Methods and interferon deficient substrates for the propagation of viruses |
| 02/24/2009 | US7494806 Genetic engineering; gene therapy; packaging cells; long terminal repeats; envelope genes/proteins |
| 02/24/2009 | US7494799 Paramunity inducers based on attenuated rabbit myxoma virus |
| 02/24/2009 | US7494660 HCV NS3-NS4A protease resistance mutants |
| 02/24/2009 | US7494659 Live attenuated influenza vaccine |
| 02/24/2009 | US7494656 virus-like particle comprising at least one protein and mutein bound to influenza antigens or epitopes, used for inducing immune responsesv in particular antibody responses and for prevention or treatment of infections, allergies, cancer, drug addiction and poisoning |
| 02/24/2009 | CA2370372C Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| 02/24/2009 | CA2360437C Method of acquiring immunological tolerance |
| 02/24/2009 | CA2312943C Constitutive expression of non-infectious hiv-like particles |
| 02/24/2009 | CA2174556C Recombinant p53 adenovirus methods and compositions |
| 02/19/2009 | WO2009023763A1 Novel clostridium perfringens bacteriophage and uses thereof |
| 02/19/2009 | WO2009023360A2 Bacterial packaging strains useful for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 02/19/2009 | US20090047728 Adenoviral vectors for influenza virus production |
| 02/19/2009 | US20090047727 Novel Clostridium perfringens Bacteriophage and Uses Thereof |
| 02/19/2009 | US20090047726 Novel Clostridium perfringens Bacteriophage and Uses Thereof |